By Josh White
Date: Tuesday 29 Aug 2023
(Sharecast News) - Immunotherapy developer Scancell announced the appointment of Sath Nirmalananthan as its new chief financial officer on Tuesday, effective immediately.
By Josh White
Date: Friday 02 Jun 2023
(Sharecast News) - Immunotherapy developer Scancell said on Friday that it is set to present an informative poster at the American Society of Clinical Oncology Meeting (ASCO) 2023 annual meeting in Chicago from 2 to 6 June.
By Josh White
Date: Tuesday 21 Feb 2023
(Sharecast News) - Immunotherapy developer Scancell announced the completion of the monotherapy dose-finding arm of the phase 1 and 2 'ModiFY' clinical trial on Tuesday.
Currency | UK Pounds |
Share Price | 9.60p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 17.00 |
52 Week Low | 8.15 |
Volume | 148,854 |
Shares Issued | 927.98m |
Market Cap | £89.09m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
14:45 | 124,469 @ 9.45p |
12:56 | 1,000 @ 9.40p |
12:48 | 750 @ 9.50p |
12:40 | 21,000 @ 9.50p |
12:19 | 100 @ 9.50p |
CEO | Lindy Durrant |
CFO | Sath Nirmalananthan |
You are here: research